Clinical Study
Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
Table 5
Spearman correlation coefficients between PGI-I/CGI-I and changes in UPDRS scores and OFF time in patients with early PD and advanced PD.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PGI-I: Patient-rated Global Impression of Improvement; CGI-I: Clinician-rated Global Impression of Improvement. |